Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920

Apolipoprotein E: Far More Than a Lipid Transport Protein

Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836

Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories

Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales

(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338

Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease

Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769

[Metabolic difference between visceral fat and subcutaneous abdominal fat].

Björntorp, P. A. (2000) · PubMed · Cited by 60

The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype

Pletniková, O., Kageyama, Y., Rudow, G. L., LaClair, K. D., Albert, M., Crain, B. J., Tian, J., Fowler, D. R., & Troncoso, J. C. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.007 · Cited by 57

Mechanisms Underlying Brain Aging Under Normal and Pathological Conditions

Jin, M., & Cai, S. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00969-9 · Cited by 61

Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease

Sternberg, Z., Hu, Z., Sternberg, D. S., Waseh, S., Quinn, J. F., Wild, K., Kaye, J. A., Zhao, L., & Garrick, M. D. (2017) · Aging and Disease · doi:10.14336/ad.2016.0811 · Cited by 57

Seizure in Alzheimer’s Disease: An Underestimated Phenomenon

Asadollahi, M., Atazadeh, M., & Noroozıan, M. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317518813551 · Cited by 56

Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study

Xiong, C., Jasielec, M. S., Weng, H., Fagan, A. M., Benzinger, T. L. S., Head, D., Hassenstab, J., Grant, E., Sutphen, C. L., Buckles, V., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002593 · Cited by 54

Interactions of metals and Apolipoprotein E in Alzheimer’s disease

Xu, H. J., Finkelstein, D. I., & Adlard, P. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00121 · Cited by 56

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Jiang, Y., Zhou, X., Wong, H. Y., Ouyang, L., Ip, F. C. F., Chau, V. M. N., Lau, S., Wu, W., Wong, D. Y. K., Seo, H., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00241-9 · Cited by 56

Alzheimer disease: Multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches

Mahley, R. W., & Huang, Y. (2009) · Annals of Neurology · doi:10.1002/ana.21736 · Cited by 53

Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype

Bangen, K. J., Initiative, F. T. A. D. N., Clark, A. L., Werhane, M., Edmonds, E. C., Nation, D. A., Evangelista, N., Libon, D. J., Bondi, M. W., & Delano-Wood, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150900 · Cited by 51

The Delayed Neuropathological Consequences of Traumatic Brain Injury in a Community-Based Sample

Postupna, N. O., Rose, S. E., Gibbons, L. E., Coleman, N., Hellstern, L. L., Ritchie, K., Wilson, A. M., Cudaback, E., Li, X., Melief, E. J., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.624696 · Cited by 51

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Initiative, A. D. N., Liu, Y., Tan, L., Wang, H.-F., Liu, Y., Hao, X., Tan, C., Jiang, T., Liu, B., Zhang, D., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9388-7 · Cited by 54

Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid

Leoni, V., & Caccia, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.015 · Cited by 48

Alzheimer's Disease: Another Target for Heparin Therapy

Bergamaschini, L. C., Rossi, E., Vergani, C., & Simoni, M. G. D. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.100 · Cited by 46

Increased florbetapir binding in the temporal neocortex from age 20 to 60 years

Gonneaud, J., Arenaza‐Urquijo, E. M., Mézenge, F., Landeau, B., Gaubert, M., Bejanin, A., de Florès, R., Wirth, M., Tomadesso, C., Poisnel, G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004733 · Cited by 49

Cerebrospinal Fluid Soluble Amyloid-β Protein Precursor as a Potential Novel Biomarkers of Alzheimer's Disease

Lewczuk, P., Popp, J., Lelental, N., Kölsch, H., Maier, W., Kornhuber, J., & Jessen, F. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110857 · Cited by 44

Common Genetic Variants Associated with Sudden Cardiac Death: The FinSCDgen Study

Lahtinen, A. M., Noseworthy, P. A., Havulinna, A. S., Jula, A., Karhunen, P. J., Kettunen, J., Perola, M., KONTULA, K. K., Newton‐Cheh, C., & Salomaa, V. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041675 · Cited by 44

Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects

Dong, Q., Zhang, W., Wu, J., Li, B., Schron, E. H., McMahon, T., Shi, J., Gutman, B. A., Chen, K., Baxter, L. C., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101744 · Cited by 44

Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease

Schmitz, T. W., Soreq, H., Poirier, J., & Spreng, R. N. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1184-19.2019 · Cited by 47

The relevance of beta-amyloid on markers of Alzheimer’s disease in clinically normal individuals and factors that influence these associations

Mormino, E. C. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9267-4 · Cited by 44

Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism

Nielsen, H. M., Chen, K., Lee, W., Chen, Y., Bauer, R. J., III, Reiman, E. M., Caselli, R. J., & Bu, G. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0231-9 · Cited by 44

Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease

Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 46

Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?

Staurenghi, E., Giannelli, S., Testa, G., Sottero, B., Leonarduzzi, G., & Gamba, P. (2021) · Antioxidants · doi:10.3390/antiox10121890 · Cited by 44

Interaction between Alzheimer’s Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

Kim, S. E., Kim, H. J., Jang, H., Weiner, M. W., DeCarli, C. S., Na, D. L., & Seo, S. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810490 · Cited by 42

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Schofield, P. W., Ebrahimi, H., Jones, A. L., Bateman, G. A., & Murray, S. R. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-24 · Cited by 43

HSV presence in brains of individuals without dementia: the TASTY brain series

Olsson, J., Lövheim, H., Honkala, E., Karhunen, P. J., Elgh, F., & Kok, E. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026674 · Cited by 43

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease

Patra, K., Soosaipillai, A. R., Sando, S. B., Lauridsen, C., Berge, G., Møller, I., Grøntvedt, G. R., Bråthen, G., Begcevic, I., Moussaud, S., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0336-4 · Cited by 45

Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism

McMillan, I. O., Li, J., & Wang, L. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00247.2022 · Cited by 49

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets

Zhang, L., Xia, Y., & Gui, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1199434 · Cited by 41

The pleiotropic vasoprotective functions of high density lipoproteins (HDL)

Boyce, G. K., Button, E. B., Sonja, S. V., & Wellington, C. L. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160103 · Cited by 41

The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older

Izaks, G. J., Gansevoort, R. T., van der Knaap, A. M., Navis, G. J., Dullaart, R. P. F., & Slaets, J. P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027415 · Cited by 42

Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices

Wang, H., Shen, Y., Chuang, H.-Y., Chiu, C., Ye, Y., & Zhao, L. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190503151648 · Cited by 43

Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice

Giannisis, A., Patra, K., Edlund, A. K., Nieto, L. A., Benedicto-Gras, J., Moussaud, S., de la Rosa, A., Twohig, D., Bengtsson, T., Fu, Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01548-0 · Cited by 40

Recent Aspects of Periodontitis and Alzheimer’s Disease—A Narrative Review

Cichońska, D., Mazuś, M., & Kusiak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052612 · Cited by 47

Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk

Sugarman, M. A., Woodard, J. L., Nielson, K. A., Seidenberg, M., Smith, J. C., Durgerian, S., & Rao, S. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.016 · Cited by 41

Longitudinal validity of PET‐based staging of regional amyloid deposition

Jelistratova, I., Teipel, S. J., & Grothe, M. J. (2020) · Human Brain Mapping · doi:10.1002/hbm.25121 · Cited by 39

Alcohol Withdrawal and Brain Injuries: Beyond Classical Mechanisms

Jung, M., & Metzger, D. (2010) · Molecules · doi:10.3390/molecules15074984 · Cited by 47

The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s

Prasanth, M. I., Malar, D. S., Tencomnao, T., & Brimson, J. M. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1939681 · Cited by 40

Alzheimer and Vascular Neuropathological Changes Associated with Different Cognitive States in a Non-Demented Sample

Stephan, B. C. M., Matthews, F. E., Ma, B., Terrera, G. M., Hunter, S., Davis, D. H. J., McKeith, I. G., Foster, G., Ince, P. G., & Brayne, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110518 · Cited by 40

Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models

Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39

PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD

Pilotto, F., Schmitz, A., Maharjan, N., Diab, R., Odriozola, A., Tripathi, P., Yamoah, A., Scheidegger, O., Oestmann, A., Dennys, C. N., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02494-5 · Cited by 36

Methylglyoxal in the Brain: From Glycolytic Metabolite to Signalling Molecule

Yang, Z., Zhang, W., Han, L., & Cai, S. (2022) · Molecules · doi:10.3390/molecules27227905 · Cited by 36

APOE4 predicts amyloid-β in cortical brain biopsy but not idiopathic normal pressure hydrocephalus

Pyykkö, O. T., Helisalmi, S., Koivisto, A. M., Mölsä, J. A. A., Rummukainen, J. K., Nerg, O., Alafuzoff, I. I., Savolainen, S., Soininen, H. S., Jääskeläinen, J. E., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-303849 · Cited by 38

Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline

Nock, T. G., Chouinard‐Watkins, R., & Plourde, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.004 · Cited by 37

Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β

Chai, A. B., Lam, H. H. J., Kockx, M., & Gelissen, I. C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158980 · Cited by 41

APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer′s disease

Zhang, W., Hu, C., Yang, Z., Zhou, Q., Peng, D., Yuan, X., Lv, Z., Pang, S., Jiang, W., Yang, C., et al. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.130117 · Cited by 36

Human Brain Reacts to Transcranial Extraocular Light

Sun, L., Peräkylä, J., Kovalainen, A., Ogawa, K. H., Karhunen, P. J., & Hartikainen, K. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149525 · Cited by 36

Electrochemical detection of specific interactions between apolipoprotein E isoforms and DNA sequences related to Alzheimer’s disease

Lima, D., Hacke, A. C. M., Inaba, J., Pessôa, C. A., & Kerman, K. (2019) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2019.107447 · Cited by 37

APOE4 moderates effects of cortical iron on synchronized default mode network activity in cognitively healthy old‐aged adults

Kagerer, S. M., Bergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Studer, S. T., Treyer, V., Meyer, R., Kaufmann, P. A., Nitsch, R. M., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12002 · Cited by 37

Astrocytic expression of the Alzheimer’s disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models

Jablonski, A. M., Warren, L., Usenovic, M., Zhou, H. H., Sugam, J. A., Parmentier‐Batteur, S., & Voleti, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-82901-1 · Cited by 38

APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia

Blackman, J., Love, S., Sinclair, L. I., Cain, R., & Coulthard, E. J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00992-y · Cited by 37

CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques

Kok, E., Luoto, T. M., Haikonen, S., Goebeler, S., Haapasalo, H. K., & Karhunen, P. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt71 · Cited by 36

A History of Senile Plaques: From Alzheimer to Amyloid Imaging

Beach, T. G. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac030 · Cited by 37

Longitudinal change in working memory as a function of APOE genotype in midlife and old age

Greenwood, P. M., Espeseth, T., Lin, M., Reinvang, I., & Parasuraman, R. (2014) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12123 · Cited by 37

APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia

Preman, P., Moechars, D., Fertan, E., Wolfs, L., Serneels, L., Shah, D., Lamote, J., Poovathingal, S., Snellinx, A., Mancuso, R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00162-7 · Cited by 32

Recognition memory is associated with altered resting‐state functional connectivity in people at genetic risk for Alzheimer's disease

Matura, S., Prvulovic, D., Butz, M., Hartmann, D., Sepanski, B., Linnemann, K., Oertel‐Knöchel, V., Karakaya, T., Fußer, F., Pantel, J., et al. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12659 · Cited by 32

Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan

Iacono, D., & Feltis, G. C. (2019) · Aging · doi:10.18632/aging.101757 · Cited by 36

Variability in objective sleep is associated with Alzheimer’s pathology and cognition

Fenton, L. E., Isenberg, A. L., Aslanyan, V., Albrecht, D., Contreras, J. A., Stradford, J., Monreal, T. K., & Pa, J. (2023) · Brain Communications · doi:10.1093/braincomms/fcad031 · Cited by 31

AMPK γ2 subunit gene PRKAG2 polymorphism associated with cognitive impairment as well as diabetes in old age

Kim, E., Lee, S. H., Lee, K. S., Cheong, H., Namkoong, K., Hong, C. H., & Oh, B. H. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.005 · Cited by 31

Alzheimer’s disease: diagnostics, prognostics and the road to prevention

Grossman, I., Lutz, M. W., Crenshaw, D. G., Saunders, A. M., Burns, D. K., & Roses, A. D. (2010) · EPMA Journal · doi:10.1007/s13167-010-0024-3 · Cited by 37

Vascular Contributions in Alzheimer’s Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population

Wijesinghe, P., Shankar, S. K., Yasha, T. C., Gorrie, C. A., Amaratunga, D., Hulathduwa, S., Kumara, K. S., Samarasinghe, K., Suh, Y., Steinbusch, H. W. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160425 · Cited by 30

Cerebrospinal Fluid Markers for Alzheimer's Disease over the Lifespan: Effects of Age and the APOEε4 Genotype

Popp, J., Lewczuk, P., Frommann, I., Kölsch, H., Kornhuber, J., Maier, W., & Jessen, F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100561 · Cited by 36

Beer Drinking Associates with Lower Burden of Amyloid Beta Aggregation in the Brain: Helsinki Sudden Death Series

Kok, E., Karppinen, T. T., Luoto, T. M., Alafuzoff, I. I., & Karhunen, P. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13102 · Cited by 27

Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses

Alhajraf, F., Ness, D., Hye, A., & Strydom, A. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22715 · Cited by 27

Prospects of Saffron and its Derivatives in Alzheimer’s Disease

Zandi, N., Pazoki, B., Roudsari, N. M., Lashgari, N., Jamshidi, V., Momtaz, S., Abdolghaffari, A. H., & Akhondzadeh, S. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.35 · Cited by 25

Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer's disease-associated pathogenic effects of apoE4 forms

Mountaki, C., Dafnis, I., Panagopoulou, E. A., Vasilakopoulou, P. B., Karvelas, M., Chiou, A., Karathanos, V. Τ., & Chroni, A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.022 · Cited by 28

Knowing Me, Knowing You: Can a Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease?

Sutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 26

Appraisal of Cognition in Preclinical Alzheimer’s Disease: A Conceptual Review

Knopman, D. S., & Caselli, R. J. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.5 · Cited by 29

Associations of Apolipoprotein E ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players

Hunter, L. E., Freudenberg‐Hua, Y., Davies, P., Kim, M., Lipton, R. B., Stewart, W. F., Srinivasan, P., Hu, S., & Lipton, M. L. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4828 · Cited by 26

Associations Between APOE Variants, Tau and α-Synuclein

Rodriguez‐Vieitez, E., & Nielsen, H. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_15 · Cited by 24

The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer’s Disease Modeling

Lee, C., Willerth, S. M., & Nygaard, H. B. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101804 · Cited by 24

Bilingualism as a Contributor to Cognitive Reserve: What it Can do and What it Cannot do

Berkes, M., & Bialystok, E. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221091417 · Cited by 26

Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer’s Disease Continuum

Uchida, Y., Onda, K., Hou, Z., Troncoso, J. C., Mori, S., & Oishi, K. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230452 · Cited by 23

Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach

Affuso, F., Micillo, F., & Fazio, S. (2024) · Biomedicines · doi:10.3390/biomedicines12081888 · Cited by 25

Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase

Wee, A. S., Nhu, T. D., Khaw, K. Y., Tang, K. S., & Yeong, K. Y. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21999221111102343 · Cited by 24

Vascular risk factors, apolipoprotein E, and hippocampal decline on magnetic resonance imaging over a 10‐year follow‐up

den Heijer, T., van der Lijn, F., Ikram, M. A., Koudstaal, P. J., van der Lugt, A., Krestin, G. P., Vrooman, H. A., Albert Hofman, D., Niessen, W. J., & Breteler, M. M. B. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.07.005 · Cited by 22

Upstream Transcription Factor 1 (USF1) Polymorphisms Associate with Alzheimer's Disease‐related Neuropathological Lesions: Tampere Autopsy Study

Isotalo, K., Kok, E., Luoto, T., Haikonen, S., Haapasalo, H., Lehtimäki, T., & Karhunen, P. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00586.x · Cited by 24

Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population

Lahtinen, A. M., Havulinna, A. S., Noseworthy, P. A., Jula, A., Karhunen, P. J., Perola, M., Newton‐Cheh, C., Salomaa, V. V., & KONTULA, K. K. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.783995 · Cited by 21

Cognitively Normal APOE ε4 Carriers Have Specific Elevation of CSF SNAP-25

Butt, O. H., Long, J. M., Henson, R. L., Herries, E. M., Sutphen, C. L., Fagan, A. M., Cruchaga, C., Ladenson, J. H., Holtzman, D. M., Morris, J. C., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.008 · Cited by 21

Effect of Aluminum-Maltolate on the Content of Aβ Protein and the Expression of ApoER2, VLDLRs, and LRP1 in PC12-ApoE4 Cells

Zhang, T., Wang, S., & Niu, Q. L. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-9995-6 · Cited by 20

Functional Magnetic Resonance Imaging in Aging and Dementia: Detection of Age-Related Cognitive Changes and Prediction of Cognitive Decline

Woodard, J. L., & Sugarman, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_159 · Cited by 20

The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors

Gläser, E., Kilimann, I., Platen, M., Hoffmann, W. U., Brosseron, F., Büerger, K., Coenjaerts, M., Düzel, E., Ewers, M., Fließbach, K., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01785-9 · Cited by 19

Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer’s disease

Llibre‐Guerra, J. J., Iaccarino, L., Coble, D., Edwards, L., Li, Y., McDade, E., Strom, A., Gordon, B. A., Mundada, N. S., Schindler, S. E., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad280 · Cited by 21

APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice

Balu, D., Valencia‐Olvera, A. C., Islam, Z., Mielczarek, C., Hansen, A. L., Ramos, T. M. P., York, J. M., LaDu, M. J., & Tai, L. M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1279343 · Cited by 20

A cortical form of CADASIL with cerebral Aβ amyloidosis

Paquet, C., Jouvent, É., Miné, M., Vital, A., Hugon, J., Chabriat, H., & Gray, F. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0758-y · Cited by 19

Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson’s and Alzheimer’s Diseases

Franco, R., Navarro, G., & Martínez‐Pinilla, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133297 · Cited by 17

Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer’s Disease and Cognitive Decline

Stonnington, C. M., Velgos, S. N., Chen, Y., Syed, S., Huentelman, M. J., Thiyyagura, P., Lee, W., Richholt, R., Caselli, R. J., Locke, D. E. C., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200132 · Cited by 18

APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid1

Berger, M., Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszeski, J. L., VanDusen, K. W., Thompson, J. W., Moseley, M. A., Devinney, M. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200747 · Cited by 15

CRP gene variation affects early development of Alzheimer's disease-related plaques

Kok, E., Alanne-Kinnunen, M., Isotalo, K., Luoto, T., Haikonen, S., Goebeler, S., Perola, M., Hurme, M. A., Haapasalo, H., & Karhunen, P. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-96 · Cited by 16

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease

Kumar, N. T., Liestøl, K., Løberg, E. M., Reims, H. M., & Mæhlen, J. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1772-1 · Cited by 16

Characterization of Amyloid-β Deposits in Bovine Brains

Costassa, E. V., Fiorini, M., Zanusso, G., Peletto, S., Acutis, P. L., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151007 · Cited by 16

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease

Dumurgier, J., Gabelle, A., Vercruysse, O., Bombois, S., Laplanche, J., Peoc’h, K., Schraen‐Maschke, S., Sablonnière, B., Pasquier, F., Touchon, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.023 · Cited by 17

ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease

Vossel, K. A., Bien‐Ly, N., Bernardo, A., Rascovsky, K., Karydas, A., Rabinovici, G. D., Sidhu, M., Huang, E. J., Miller, B. L., Huang, Y., et al. (2012) · Neurocase · doi:10.1080/13554794.2012.667124 · Cited by 16

Alzheimer's Disease

Noroozıan, M. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.08.005 · Cited by 18

Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study

The EMAS Study Group, Overman, M. J., Pendleton, N., O’Neill, T. W., Bártfai, G., Casanueva, F. F., Finn, J. D., Forti, G., Rastrelli, G., Giwercman, A., et al. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1247-4 · Cited by 16

CSF cutoffs for MCI due to AD depend on APOEε4 carrier status

Marizzoni, M., Ferrari, C., Babiloni, C., Albani, D., Barkhof, F., Cavaliere, L., Didic, M., Forloni, G., Fusco, F., Galluzzi, S., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.019 · Cited by 15

Contributions of sex and genotype to exploratory behavior differences in an aged humanized APOE mouse model of late-onset Alzheimer's diseasePreprint

McLean, J. W., Bhattrai, A., Vitali, F., Raikes, A. C., Wiegand, J. L., & Brinton, R. D. (2022) · Learning & Memory · doi:10.1101/lm.053588.122 · Cited by 15

Common occurrence of atrophic gastritis in an ageing non-hospitalised population: an autopsy study

Karhunen, P. J., Tuomisto, S., Goebeler, S., Martiskainen, M., & Kok, E. (2025) · Age and Ageing · doi:10.1093/ageing/afaf047 · Cited by 14

Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau

Butt, O. H., Meeker, K. L., Wisch, J. K., Schindler, S. E., Fagan, A. M., Benzinger, T. L. S., Cruchaga, C., Holtzman, D. M., Morris, J. C., & Ances, B. M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12375 · Cited by 12

The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype

Pletniková, O., Kageyama, Y., Rudow, G. L., LaClair, K. D., Albert, M., Crain, B. J., Tian, J., Fowler, D. R., & Troncoso, J. C. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.007 · Cited by 57

Apolipoprotein E4 Promotes Incipient Alzheimer Pathology in the Elderly

Warzok, R., Kessler, C., Apel, G., Schwarz, A., Egensperger, R., Schreiber, D., Herbst, E. W., Wolf, E., Walther, R., & Walker, L. C. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199803000-00005 · Cited by 67

Gender and age modify the association between APOE and AD-related neuropathology

Ghebremedhin, E., Schultz, C., Thal, D. R., Rüb, U., Ohm, T. G., Braak, E., & Braak, H. (2001) · Neurology · doi:10.1212/wnl.56.12.1696 · Cited by 108

P1‐207: Alzheimer's lesions in the brains of young subjects

Pletniková, O., Rudow, G. L., Hyde, T. M., Kleinman, J. E., Ali, S. Z., Bharadwaj, R. A., Crain, B. J., Fowler, D. R., Rubio, A. I., & Troncoso, J. C. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.407

The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.

Landén, M., Thorsell, A., Wallin, A., & Blennow, K. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.4.352 · Cited by 55